[go: up one dir, main page]

WO1995007279A3 - Procede pour la preparation de derives d'indolizine - Google Patents

Procede pour la preparation de derives d'indolizine Download PDF

Info

Publication number
WO1995007279A3
WO1995007279A3 PCT/JP1994/001465 JP9401465W WO9507279A3 WO 1995007279 A3 WO1995007279 A3 WO 1995007279A3 JP 9401465 W JP9401465 W JP 9401465W WO 9507279 A3 WO9507279 A3 WO 9507279A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
indolizine derivatives
indolizine
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1994/001465
Other languages
English (en)
Other versions
WO1995007279A2 (fr
Inventor
Satoshi Okada
Kozo Sawada
Akio Kuroda
Shinya Watanabe
Hirokazu Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to US08/592,309 priority Critical patent/US5780633A/en
Priority to DE69414586T priority patent/DE69414586T2/de
Priority to EP94925630A priority patent/EP0717742B1/fr
Priority to KR1019960701139A priority patent/KR100339068B1/ko
Priority to JP50858195A priority patent/JP3160909B2/ja
Publication of WO1995007279A2 publication Critical patent/WO1995007279A2/fr
Publication of WO1995007279A3 publication Critical patent/WO1995007279A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention se rapporte à un nouveau procédé pour la préparation d'un composé représenté par la formule (I).
PCT/JP1994/001465 1993-09-10 1994-09-06 Procede pour la preparation de derives d'indolizine Ceased WO1995007279A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US08/592,309 US5780633A (en) 1993-09-10 1994-09-06 Process for the preparation of indolizine derivatives
DE69414586T DE69414586T2 (de) 1993-09-10 1994-09-06 Verfahren zur herstellung von indolizinderivaten
EP94925630A EP0717742B1 (fr) 1993-09-10 1994-09-06 Procede pour la preparation de derives d'indolizine
KR1019960701139A KR100339068B1 (ko) 1993-09-10 1994-09-06 인돌리진유도체의제조방법
JP50858195A JP3160909B2 (ja) 1993-09-10 1994-09-06 インドリジン誘導体の製造法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9318790.4 1993-09-10
GB939318790A GB9318790D0 (en) 1993-09-10 1993-09-10 Heterocyclic derivatives

Publications (2)

Publication Number Publication Date
WO1995007279A2 WO1995007279A2 (fr) 1995-03-16
WO1995007279A3 true WO1995007279A3 (fr) 1995-04-27

Family

ID=10741816

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1994/001465 Ceased WO1995007279A2 (fr) 1993-09-10 1994-09-06 Procede pour la preparation de derives d'indolizine

Country Status (12)

Country Link
US (1) US5780633A (fr)
EP (1) EP0717742B1 (fr)
JP (1) JP3160909B2 (fr)
KR (1) KR100339068B1 (fr)
CN (1) CN1043992C (fr)
AT (1) ATE173259T1 (fr)
CA (1) CA2171308A1 (fr)
DE (1) DE69414586T2 (fr)
ES (1) ES2127937T3 (fr)
GB (1) GB9318790D0 (fr)
HU (1) HU216156B (fr)
WO (1) WO1995007279A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934318A1 (fr) * 1996-10-01 1999-08-11 Glycodesign Inc. Nouveaux analogues de swainsonine substitues en position 3, 5 et/ou 6, leurs procedes de preparation et leur utilisation en tant qu'agents therapeutiques
CA2286766A1 (fr) 1997-04-15 1998-10-22 Glycodesign Inc. Sels halogenes d'alcaloide de swainsonine et procedes d'utilisation
AU9617298A (en) * 1997-10-24 1999-05-17 Glycodesign Inc. Synthesis of swainsonine salts
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
CA2585967A1 (fr) 2004-11-01 2006-05-11 Wyeth Indolizines substituees et derives utilises comme agents du systeme nerveux central

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519353A2 (fr) * 1991-06-17 1992-12-23 Fujisawa Pharmaceutical Co., Ltd. Dérivés d'indolizine, procédé pour leur préparation et compositions pharmaceutiques les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3316272A (en) 1962-06-27 1967-04-25 Richardson Merrell Inc Heterocyclic derivatives of triphenyl-ethylenes, triphenylethanes and triphenylethanols
US3306895A (en) 1962-06-27 1967-02-28 Richardson Merrell Inc Heterocyclic derivatives of triphenylethylenes, triphenylethanes and triphenylethanols
US4000143A (en) 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US3931195A (en) 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519353A2 (fr) * 1991-06-17 1992-12-23 Fujisawa Pharmaceutical Co., Ltd. Dérivés d'indolizine, procédé pour leur préparation et compositions pharmaceutiques les contenant

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C. CASAGRANDE ET AL.: "Indolizine Analogues of Indomethacin", IL FARMACO EDIZIONE SCIENTIFICA, vol. XXVI, no. 12, 1971, pages 1059 - 1073 *
T. UCHIDA, K. MATSUMOTO: "Methods for the Construction of the Indolizine Nucleus", SYNTHESIS, no. 4, 1976, pages 209 - 236 *
Y. TAMURA ET AL.: "Formation of Indolizines via Pyridinium 8-Carbomethoxyallylides", CHEM. PHARM. BULL., vol. 20, no. 5, 1972, pages 1058 - 1061 *

Also Published As

Publication number Publication date
CN1130907A (zh) 1996-09-11
EP0717742A1 (fr) 1996-06-26
HUT74290A (en) 1996-11-28
HU216156B (hu) 1999-04-28
ATE173259T1 (de) 1998-11-15
DE69414586T2 (de) 1999-04-29
WO1995007279A2 (fr) 1995-03-16
JPH09502200A (ja) 1997-03-04
GB9318790D0 (en) 1993-10-27
ES2127937T3 (es) 1999-05-01
KR100339068B1 (ko) 2002-11-23
EP0717742B1 (fr) 1998-11-11
KR960704889A (ko) 1996-10-09
CN1043992C (zh) 1999-07-07
US5780633A (en) 1998-07-14
DE69414586D1 (de) 1998-12-17
HU9600606D0 (en) 1996-05-28
CA2171308A1 (fr) 1995-03-16
JP3160909B2 (ja) 2001-04-25

Similar Documents

Publication Publication Date Title
CA2207694A1 (fr) Procede pour l'obtention du sildenafil
AU8225491A (en) Process for preparing dibenzylidene-d-sorbitol compounds
AU7622391A (en) Process for the preparation of a polyolefin
AU3548993A (en) Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
AU3676393A (en) Process for the preparation of a biphenyl derivative
AU7618691A (en) Process for the preparation of a polyolefin
AU1142192A (en) Process for the preparation of 13c-labelled compounds
WO1995007279A3 (fr) Procede pour la preparation de derives d'indolizine
AU3384693A (en) Process for preparing sulphonylurea salts
AU1302088A (en) Process for the preparation of a macrocyclic compound
AU1077992A (en) Process for preparing 1,3-dioxols
AU8463691A (en) Processes for the preparation of nitrogen-containing compounds
AU6761794A (en) Process for the preparation of a linear aldehyde organic compound
AU9004591A (en) 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof
AU8251891A (en) Process for the preparation of 1-alkylisoquinoline derivatives
AU8457591A (en) Process for the preparation of carbapenem compounds
CA2001083A1 (fr) Derive de s-timolol nouveau et procede de preparation correspondant
AU682412B2 (en) Process for preparing imidazopyridine derivatives
EP0374410A3 (fr) Acide 2-azabicyclo(2.2.1)hept-5-ène-2-acétique, dérivés de celui-ci et composés apparentés, procédé pour la préparation de ces composés et l'utilisation de ces composés pour la préparation de N-phosphonométhylglycine
AU658632B2 (en) A microbiological process for the preparation of 5-hydroxypyrazinoic acid
AU646436B2 (en) Processes for preparing 2-halogeno-3-hydroxy-3- phenylpropionic acid ester compounds
AU5808294A (en) A process for the preparation of 2,3,5,6-tetrachloropyridine
GR1001203B (el) Μεθοδος παρασκευης της ενωσεως 24r-σκυμνολη.
GB2272218B (en) Process for the preparation of 2,4,6-triiodo-isophthalic acid bis-(1,3-dihydroxypropylamide) derivatives
AU5318398A (en) Process for the preparation of an oligomeric compound

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 94193336.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): CA CN HU JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA CN HU JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1994925630

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2171308

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 08592309

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1994925630

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1994925630

Country of ref document: EP